AVITA Medical (RCEL) Capital Expenditures (2019 - 2025)
AVITA Medical (RCEL) posted Capital Expenditures of $106000.0 for Q4 2025, down 54.89% on a QoQ basis from $235000.0 in Q3 2025, and up 136.3% year-over-year from $44858.0 in Q4 2024.
AVITA Medical (RCEL) Capital Expenditures (2019 - 2025) Analysis & Trends
AVITA Medical's Capital Expenditures history runs 7 years deep, the most recent figure standing at $106000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 136.3% year-over-year to $106000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $635000.0 (up 452.17% YoY) and the FY2025 annual result came in at $635000.0, up 452.17% from the prior year.
- Capital Expenditures was $106000.0 for Q4 2025 at AVITA Medical, down from $235000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.1 million in Q1 2024 and bottomed at -$1.1 million in Q4 2022.
- A 5-year average of $158000.0 and a median of $221000.0 in 2025 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 12744344.44% in 2024, while the deepest fall reached 238.08% in 2024.
- AVITA Medical's Capital Expenditures stood at $763000.0 in 2021, then sank by 239.06% to -$1.1 million in 2022, then jumped by 127.9% to $296000.0 in 2023, then tumbled by 198.65% to -$292000.0 in 2024, then soared by 136.3% to $106000.0 in 2025.
- Business Quant data shows RCEL's Capital Expenditures at $106000.0 in Q4 2025, $235000.0 in Q3 2025, and $73000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | -292,000.00 |
| Dec 31, 2024 | -292,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | -805,000.00 |
| Jun 30, 2024 | -805,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 296,000.00 |
| Dec 31, 2023 | 296,000.00 |
| Sep 30, 2023 | 502,000.00 |
| Sep 30, 2023 | 502,000.00 |